|Articles|March 1, 2021
WuXi Biologics – Global Solution Provider
Author(s)WuXi Biologics
WuXi Biologics, a Hong Kong-listed company (2269.HK), is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics and vaccines from concept to commercial manufacturing. We offer a true one-stop CDMO offering from DNA to IND and a premier-quality manufacturing global supply chain network across four countries.
WuXi Biologics
108 Meiliang Road. W,
MaShan Binhu District,
Jiangsu Province
Wuxi 214092, China
Tel.+86 (510).8183.1200
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
5